Managing Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitors-Reference-Cited by-同舟云学术

Managing Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitors

Published:2011-04 Issue:2 Volume:11 Page:198-203
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Ravandi Farhad

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference64 articles.

1. The biology and therapy of adult acute lymphoblastic leukemia;Faderl;Cancer,2003

2. Philadelphia chromosome-positive acute lymphocytic leukemia: a new era of challenges;Thomas;Hematology (Am Soc Hematol Educ Program),2007

3. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia;Faderl;Blood,1998

4. Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate;Pfeifer;Clin Cancer Res,2003

5. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia;Ottmann;Hematology (Am Soc Hematol Educ Program),2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities;Annals of Hematology;2024-06-05

2. Comparison of autologous and allogeneic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia;Hematology;2021-01-01

3. Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia;Acute Leukemias;2020-10-11

4. Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal;PharmacoEconomics;2018-03-03

5. Acute Leukemia;Hematology/Oncology Clinics of North America;2017-12